A Study to Evaluate the Effects of Domperidone on Cardiac Repolarization in Healthy Volunteers

NCT01643889 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Treatment A (domperidone 10 mg)
DRUG: Treatment B (domperidone 20 mg)
DRUG: Treatment C (placebo)
DRUG: Treatment D (moxifloxacin)

Sponsor

Janssen Research & Development, LLC